MBIO 润色咨询

mBio

出版年份：2010 年文章数：5460 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：4.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2021-12-29 学医的彭于晏

    什么是correspondingauthor/通讯作者？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2021-12-27 乌云背后的幸福线

    推荐同行评议时需要注意哪些情况？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2019-10-05 ms7789161110100487

    昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：
    manuscript sent to production 2019-10-04
    manuscript ready for publication 2019-10-04
    decision letter sent to author 2019-10-04
    decision pending 2019-10-04
    with editor 2019-09-10
    manuscript submission 2019-09-10
    manuscript submission started 2019-09-10
    特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2024-04-13 ms7000000797363888 来自浙江省

    1

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2023-12-19 Descuenxk 来自德国

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：病毒学
    经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2020-12-22 wnj1738555_28787312

    审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0
    偏重的研究方向：医学;病毒
    经验分享：mbio的质量距离plos pathogens还是有差距的
    别听这个版上的无脑喷子的话
    去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS
    mbio好像一篇都没有

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2023-02-04 ms2000001468453392 来自浙江省

    在投

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2022-12-18 ms9000001911772190 来自广东省

    偏重的研究方向：天然免疫
    经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2022-08-30 ms6000000949743620

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向：病毒;微生物
    经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1103974, encodeId=eded11039e470, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103973, encodeId=f4f011039e3e1, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854101, encodeId=c0cd8541012c, content=昨天收到editor in-chief的邮件说是accepted了。贴出日期线供大家参考：<br> manuscript sent to production 2019-10-04<br> manuscript ready for publication 2019-10-04<br> decision letter sent to author 2019-10-04<br> decision pending 2019-10-04<br> with editor 2019-09-10 <br> manuscript submission 2019-09-10<br> manuscript submission started 2019-09-10<br> 特别提示：这是aam-track的时间，两个审稿已经在提交给杂志社之前完成了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d535414114, createdName=ms7789161110100487, createdTime=Sat Oct 05 20:03:54 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198256, encodeId=68aa219825625, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66be9255550, createdName=ms7000000797363888, createdTime=Sat Apr 13 10:00:04 CST 2024, time=2024-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175713, encodeId=377721e571371, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒学<br>经验分享：终于有一篇一区top，分享下时间线： 3.13投稿，当天with editor 3.20 under review 4.12 with editor 当天拒稿鼓励重投 补实验等拖拉半年多，欧洲效率哈哈 12.7重投 12.15直接accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/01/3f3636addc46b9268efbd0aac7dd284d.jpg, createdBy=12182026219, createdName=Descuenxk, createdTime=Tue Dec 19 05:38:17 CST 2023, time=2023-12-19, status=1, ipAttribution=德国), GetPortalCommentsPageByObjectIdResponse(id=909939, encodeId=b64290993914, content=审稿速度:1.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：医学;病毒<br>经验分享：mbio的质量距离plos pathogens还是有差距的<br>别听这个版上的无脑喷子的话<br>去看看每年微生物十大进展有多少发在plos pathogens 三分之一 其他三分之二在NS PNAS<br>mbio好像一篇都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07165343229, createdName=wnj1738555_28787312, createdTime=Tue Dec 22 03:39:45 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112955, encodeId=e4e4211295508, content=在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72a88520642, createdName=ms2000001468453392, createdTime=Sat Feb 04 07:08:37 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2106569, encodeId=00d421065698e, content=偏重的研究方向：天然免疫<br>经验分享：投稿with editor好几天又正好碰上周六天，是不是要拒稿所以周五不写拒稿信啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4a5495926, createdName=ms9000001911772190, createdTime=Sun Dec 18 13:45:13 CST 2022, time=2022-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1242126, encodeId=b18e12421268b, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：病毒;微生物<br>经验分享：ASM的头牌级别的；微生物领域与plos pathogens为双核，小领域期刊太少了，在网上就是Nature mcribiology/ cell host mcrobe了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5525700000, createdName=ms6000000949743620, createdTime=Tue Aug 30 21:29:35 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241130, encodeId=0342124113015, content=偏重的研究方向：病毒<br>经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Aug 26 12:17:30 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2022-08-26 ms7000000308199462

    偏重的研究方向：病毒
    经验分享：微生物病毒学领域的顶刊，虽然影响因子没有nat.microbiology cell.host等期刊高，但是由m国微生物委员会创办的期刊，文章质量也在逐年稳步提升。

    0

共108条页码: 2/11页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分